Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for refractory hypotension in ICU patients
ACTRN12618001158257Phase 3Completed
- Sponsor
- Austin Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of midodrine in hypotension, sponsored by Austin Hospital. Started Aug 2018; status: completed.
02
Drugs
midodrine
03
Conditions
hypotension
Beyond the preview
Go deeper on ACTRN12618001158257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001158257.